AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 199 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $270,000 | -25.8% | 7,623 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $364,000 | +47.4% | 7,623 | 0.0% | 0.01% | +20.0% |
Q3 2019 | $247,000 | -35.0% | 7,623 | 0.0% | 0.01% | -37.5% |
Q2 2019 | $380,000 | -26.1% | 7,623 | 0.0% | 0.01% | -33.3% |
Q1 2019 | $514,000 | -16.3% | 7,623 | -42.8% | 0.01% | -25.0% |
Q4 2018 | $614,000 | -49.1% | 13,323 | -14.8% | 0.02% | -11.1% |
Q3 2018 | $1,206,000 | +83.0% | 15,646 | +100.0% | 0.02% | +28.6% |
Q2 2018 | $659,000 | +16.4% | 7,823 | +13.0% | 0.01% | +7.7% |
Q1 2018 | $566,000 | +118.5% | 6,923 | +53.1% | 0.01% | +333.3% |
Q4 2017 | $259,000 | – | 4,523 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |